Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

The One Big Beautiful Bill Act delivers long-awaited tax clarity for distributors — but only for those who know how to use it. In this sponsored MDM Amplify Podcast, Grant Thornton leaders explain the ...

Many thanks to the sponsors of this year’s rendition, which are SAP (Platinum), BigCommerce (Gold) and Epicor (Silver) for their support and everything they do to ...

滨江集团4.86% 0.00%股吧 中国人寿4.80%--股吧 青岛银行4.80%-0.59%股吧 齐鲁银行4.79%-0.64%股吧 渝农商行4.74% 0.00%股吧 杭州银行4.74%-0. ...

洛阳钼业6.72%-0.36%股吧 中矿资源5.99%-2.68%股吧 山东黄金5.71%-1.92%股吧 华友钴业5.59% 0.29%股吧 天齐锂业4.61%-4.86%股吧 盛达资源4.48 ...